Literature DB >> 23568601

Identification of new pathogenic candidates for diabetic macular edema using fluorescence-based difference gel electrophoresis analysis.

Cristina Hernández1, Marta García-Ramírez, Nuria Colomé, Lidia Corraliza, Luis García-Pascual, Joan Casado, Francesc Canals, Rafael Simó.   

Abstract

BACKGROUND: Diabetic macular edema is the main cause of visual impairment in diabetic patients. The aim of the present study was to explore the differential proteomic pattern of the vitreous fluid from diabetic macular edema patients by means of fluorescence-based difference gel electrophoresis (DIGE).
METHODS: Samples of vitreous from eight type 2 diabetic patients [four with diabetic macular edema without proliferative diabetic retinopathy and four with proliferative diabetic retinopathy without diabetic macular edema), and eight from non-diabetic subjects with idiopathic macular hole (control group) were selected from our vitreous bank for proteomic analysis. To further confirm the potential candidates identified by DIGE, 18 additional samples (six proliferative diabetic retinopathy, six diabetic macular edema and six macular hole, matched by age) were analysed by enzyme-linked immuno sorbent assay (ELISA).
RESULTS: Selecting an abundance ratio of 1.5-fold, p < 0.05, as the threshold for the study, four proteins were specifically associated with diabetic macular edema. Hemopexin was significantly higher in the vitreous fluid of patients with diabetic macular edema in comparison with both control subjects and proliferative diabetic retinopathy patients. By contrast, clusterin, transthyretin and crystallin S were significantly decreased in the vitreous of patients with diabetic macular edema. The differential production of hemopexin, clusterin and transthyretin was further confirmed by ELISA.
CONCLUSIONS: Proteomic analysis by DIGE was useful in identifying new potential candidates involved in the pathogenesis of diabetic macular edema. These results could open up new strategies in the treatment of diabetic macular edema.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  diabetic macular edema; proteomic analysis; vitreous fluid

Mesh:

Substances:

Year:  2013        PMID: 23568601     DOI: 10.1002/dmrr.2419

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  5 in total

1.  Two-Dimensional Differential Gel Electrophoresis to Identify Protein Biomarkers in Amniotic Fluid of Edwards Syndrome (Trisomy 18) Pregnancies.

Authors:  Te-Yao Hsu; Hao Lin; Hsuan-Ning Hung; Kuender D Yang; Chia-Yu Ou; Ching-Chang Tsai; Hsin-Hsin Cheng; Su-Hai Chung; Bi-Hua Cheng; Yi-Hsun Wong; An Kuo Chou; Chang-Chun Hsiao
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

Review 2.  A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders.

Authors:  Lasse Jørgensen Cehofski; Bent Honoré; Henrik Vorum
Journal:  Int J Mol Sci       Date:  2017-04-28       Impact factor: 5.923

3.  A validated analysis pipeline for mass spectrometry-based vitreous proteomics: new insights into proliferative diabetic retinopathy.

Authors:  Sarah R Weber; Yuanjun Zhao; Jingqun Ma; Christopher Gates; Felipe da Veiga Leprevost; Venkatesha Basrur; Alexey I Nesvizhskii; Thomas W Gardner; Jeffrey M Sundstrom
Journal:  Clin Proteomics       Date:  2021-12-03       Impact factor: 3.988

Review 4.  New Insights into Treating Early and Advanced Stage Diabetic Retinopathy.

Authors:  Rafael Simó; Cristina Hernández
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

Review 5.  Proteomic Analyses of Vitreous in Proliferative Diabetic Retinopathy: Prior Studies and Future Outlook.

Authors:  Sarah R Weber; Yuanjun Zhao; Christopher Gates; Jingqun Ma; Felipe da Veiga Leprevost; Venkatesha Basrur; Alexey I Nesvizhskii; Thomas W Gardner; Jeffrey M Sundstrom
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.